Laboratorios Serono S.a.

Ares Holding 89 N.v.

Ramon Cacabelos

Francisco R Vila

Thomas O Alonso

The administration of Somatostatin and growth hormone releasing factor at useful dosage levels alleviates the symptoms of various neuropsychiatric disorders. Growth hormone and neuropsychiatric responses to the administration of growth hormone releasing factor to mammals indicate its usefulness as an antemortem marker for senile dementia of the Alzheimer's type.

Treatment of neuropsychiatric disorders

Administration of a Growth Hormone Releasing factor (GRF) at effective dosage levels improves the mental function of attention or short term memory in a subject in need of the treatment. The method of treating comprises the administration to the subject of an effective mental function improving amount of a Growth Hormone Releasing Factor.

Growing community of inventors

Santiago de Compostela, Spain

Ramon Cacabelos